Power Law company profile

Centogene

Biotech & Life Sciences · Rostock, Germany · Founded 2006 · IPO 2019 Thoroughbred

Biomarkers and companion diagnostic solutions

Valuation

$76M

Market cap · 2026

Revenue

$53M

Latest reported FY

Featured in $10B+ revenueThoroughbred · Power Law outcome

Investors

4 investors on Centogene's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 4 investors entered at this stage

Careventures

TVM Capital Life Science

Crédit Mutuel Equity

DPE Deutsche Private Equity

Global footprint

Where Centogene has talent and traffic

AI talent share

3.9% of workforce is AI talent
(18 of 467 staff)

Core AI10.21%

Other AI173.64%

Non-AI workforce44996.15%

Workforce by country

32 countries with
team presence

🇩🇪 Germany56.9%

🇪🇸 Spain9.2%

🇮🇳 India4.8%

🇧🇷 Brazil4%

🇷🇸 Serbia3.8%

Top 5 of 32 shown

Web traffic by country

11K monthly visits
across markets

🇺🇸 United States38.2%

🇸🇦 Saudi Arabia17.3%

🇩🇪 Germany11.8%

🇪🇸 Spain10.9%

🇮🇳 India10.9%

Top 5 markets shown

Market sentiment

What the market is saying about Centogene

An AI-synthesized read of the highest-engagement posts about Centogene on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Centogene on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles